Cynosure Advisors’s Allergan plc AGN Stock Holding History

Cynosure Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,122	Closed	-$347K	–	249
2017 Q4	$347K	Buy	+2,122	New	+$381K	0.08%	171

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Cynosure Advisors's AGN Position: Q1 2018 in Review

Cynosure Advisors sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,122 shares — an estimated $347K sold.

Cynosure Advisors first reported a position in AGN in Q4 2017 and held it in 1 quarter. The position peaked at $347K in Q4 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Cynosure Advisors reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Cynosure Advisors sold 2,122 Allergan plc shares in Q1 2018, an estimated $347K.
Cynosure Advisors first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Cynosure Advisors's Allergan plc position peaked at $347K in Q4 2017.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Cynosure Advisors's 13F filing for Q1 2018, filed 21 Jun 2018.